SCHEMBL7965530

SCHEMBL7965530

Cc1c(C(N)=O)c2n(c1-c1cccnc1)CCC=C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 9/20 0.40
MKNK2 Q9HBH9 8/20 0.40
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
CSNK1D P48730 1/20 0.38
CSNK1E P49674 1/20 0.38
CYP2A6 P11509 1/20 0.36
CYP11B2 P19099 3/20 0.36
TBXAS1 P24557 1/20 0.35
BTK Q06187 1/20 0.35
F7 P08709 1/20 0.35
F3 P13726 1/20 0.35
SARM1 Q6SZW1 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
SIRT6 Q8N6T7 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
SIRT3 Q9NTG7 1/20 0.35
SIRT5 Q9NXA8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7963271 0.90 CYP2A6 (0.38) MKNK1MKNK2CYP1A2CYP3A4CYP2C19
SCHEMBL8328659 0.90 GPR35 (0.38) MKNK1MKNK2LMNACYP1A2CYP3A4
SCHEMBL7963752 0.87 SLC2A1 (0.39) LMNACYP3A4CYP11B2
SCHEMBL2158254 0.86 MKNK1 (0.43) MKNK1MKNK2CSNK1DCSNK1ECYP2A6
SCHEMBL7962850 0.86 MKNK1 (0.41) MKNK1MKNK2LMNACYP1A2CYP3A4
SCHEMBL7965727 0.84 MKNK1 (0.38) MKNK1MKNK2CSNK1DCSNK1ECYP11B2
SCHEMBL7963174 0.84 MKNK1 (0.37) MKNK1MKNK2CSNK1DCSNK1ECYP11B2
SCHEMBL7963276 0.80 CYP11B2 (0.39) MKNK1MKNK2CYP1A2CYP3A4CYP2C19
SCHEMBL8328721 0.78 MKNK1 (0.38) MKNK1MKNK2CYP2A6CYP11B2
SCHEMBL7962627 0.78 DHODH (0.37) MKNK1MKNK2LMNACYP2C19CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207675-B1 FOR PROPHYLAXIS AND THERAPY OF DISEASES IN WHICH ARE INVOLVED VIRUSES OF THE HERPES FAMILY AND/OR CYTOKINES IN PARTICULAR TUMOR NERCOSIS FACTOR-ALPHA RHONE-POULENC RORER S.A. (FR) 2001-03-27 US claimed
EP-0946555-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Aventis Pharma S.A. (FR) 1999-10-06 EP claimed
WO-1998025925-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1998-06-18 WO claimed
US-6207675-B1 FOR PROPHYLAXIS AND THERAPY OF DISEASES IN WHICH ARE INVOLVED VIRUSES OF THE HERPES FAMILY AND/OR CYTOKINES IN PARTICULAR TUMOR NERCOSIS FACTOR-ALPHA RHONE-POULENC RORER S.A. (FR) 2001-03-27 US disclosed
EP-0946555-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Aventis Pharma S.A. (FR) 1999-10-06 EP disclosed
WO-1998025925-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1998-06-18 WO disclosed